Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001683168-24-005797
Filing Date
2024-08-16
Accepted
2024-08-15 20:17:56
Documents
73
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 FOR 12-31-23 coeptis_i10ka1-123123.htm   iXBRL 10-K/A 1570326
2 SUBSIDIARIES OF COEPTIS THERAPEUTICS HOLDINGS, INC. coeptis_ex2101.htm EX-21.1 2094
3 CERTIFICATION coeptis_ex3101.htm EX-31.1 13072
4 CERTIFICATION coeptis_ex3102.htm EX-31.2 13165
5 CERTIFICATION coeptis_ex3201.htm EX-32.1 4637
6 CERTIFICATION coeptis_ex3202.htm EX-32.2 4653
7 GRAPHIC image_009.jpg GRAPHIC 1197
8 GRAPHIC image_010.jpg GRAPHIC 1197
9 GRAPHIC image_011.jpg GRAPHIC 1197
10 GRAPHIC image_008.jpg GRAPHIC 2148
11 GRAPHIC image_007.jpg GRAPHIC 2148
12 GRAPHIC image_012.jpg GRAPHIC 11061
  Complete submission text file 0001683168-24-005797.txt   7397188

Data Files

Seq Description Document Type Size
13 XBRL SCHEMA FILE coep-20231231.xsd EX-101.SCH 52786
14 XBRL CALCULATION FILE coep-20231231_cal.xml EX-101.CAL 56903
15 XBRL DEFINITION FILE coep-20231231_def.xml EX-101.DEF 233780
16 XBRL LABEL FILE coep-20231231_lab.xml EX-101.LAB 414073
17 XBRL PRESENTATION FILE coep-20231231_pre.xml EX-101.PRE 346001
77 EXTRACTED XBRL INSTANCE DOCUMENT coeptis_i10ka1-123123_htm.xml XML 961857
Mailing Address 105 BRADFORD ROAD, SUITE 420 WEXFORD PA 15090
Business Address 105 BRADFORD ROAD, SUITE 420 WEXFORD PA 15090 724-934-6467
Coeptis Therapeutics Holdings, Inc. (Filer) CIK: 0001759186 (see all company filings)

EIN.: 981465952 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39669 | Film No.: 241213916
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)